Immunotherapy for Conjunctival Squamous Cell Carcinoma with Orbital Extension

Dr. Hakan Demirci discusses his study of PD-1 cell death inhibitors as an effective immunotherapy for treating locally unresectable advanced conjunctival squamous cell carcinoma with orbital extensions. Ideal patients include those with high tumor burden. The treatment offers a globe-sparing alternative to exenteration. 

Relevant Financial Disclosures: None